# ClarIDHy (NCT02989857)

> Study of AG-120 in Previously Treated Advanced Cholangiocarcinoma With IDH1 Mutations (ClarIDHy)

No report yet. It can be ordered.

- Drugs tested: ivosidenib
- Indication: previously treated advanced IDH1-mutant cholangiocarcinoma

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT02989857
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: Institut de Recherches Internationales Servier
- Conditions: Advanced Cholangiocarcinoma; Metastatic Cholangiocarcinoma
- Interventions: AG-120; Placebo
- Enrollment: 187
- Primary outcome: Progression Free Survival (PFS) as Determined by the Independent Radiology Committee (IRC)

## Indexed commentary on ClarIDHy so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 31
- Podcasts: 4
- YouTube: 2

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=claridhy-nct02989857

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT02989857", "email": "<work email>"}; the inbox owner confirms by the emailed link.